Activated Phosphoinositide 3-Kinase Delta Syndrome (APDS) Market Report (2022 to 2030) - Pfizer Inc., Novartis AG, Genentech, Inc., GlaxoSmithKline Plc. and LFB Biomedicaments
08. Februar 2023 08:00 ET
|
Growth Plus Reports
Newark, New Castle, USA, Feb. 08, 2023 (GLOBE NEWSWIRE) -- The global “Activated Phosphoinositide 3-Kinase Delta Syndrome (APDS) Market Size” is expected to rise with an impressive CAGR of 6.2% and...